ALPHA COGNITION

Neurodyn utilizes a portfolio approach to identify, validate, and develop bioactives for neuroprotection and the early treatment of neurological diseases. Neurodyn identifies bioactive compounds within historically-proven natural treatments with the goal of validating therapeutic candidates and ultimately developing treatments for Parkinson’s, Alzheimer’s, ALS, and chronic nerve pain. Neurodyn will out-license or sell validated therapeutic candidates to pharmaceutical and consumer health pla... yers, as well as explore faster alternatives to traditional drug development, such as the US FDA Medical Food designation. Neurodyn’s unique insight into the discovery, validation, and development of new bioactive compounds comes from a strong development capacity based on international partners with demonstrated historical knowledge of natural compounds, in-house medicinal chemistry capability, and proprietary animal models of neurological disease.

#SimilarOrganizations #People #Event #Website #More

ALPHA COGNITION

Social Links:

Industry:

Health Care Pharmaceutical

Founded:

2014-01-01

Address:

Vancouver, British Columbia, Canada

Country:

Canada

Website Url:

http://www.alphacognition.com

Total Employee:

Status:

Active

Contact:

(604) 684-3323

Email Addresses:

[email protected]

Total Funding:

6.6 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics